Conclusion: Beyond the Scale The excitement around GLP-1 medications started with weight loss, but the science is showing us a much bigger picture
They plan meals that are easier to tolerate, keep hydration consistent, and show up for dose adjustments when needed
There appear to be no reliable predictors of persistent recovery of EF among 408 patients with DCM, who initially experienced improvement, according to a long-term follow-up study 27
Structural motifs in eIF4G and 4E-BPs modulate their binding to eIF4E to regulate translation initiation in yeast
Supplementary Figures Individual cytokine results Dorsal hippocampus There was a trend towards lower levels of IL-1 in GE2-treated compared to vehicle-treated females ( p = 0.054, Cohens d =0.910
Glucagon-like peptide-1 (GLP-1) medications, like Ozempic and Wegovy, have transformed the way diabetes and weight are managed